2013
DOI: 10.1016/j.idc.2013.08.001
View full text
|
|

Abstract: Neisseria gonorrhoeae has developed resistance to all previous first-line antimicrobial therapies recommended by the United States’ Centers for Disease Control and Prevention over the past 75 years. Now the cephalosporins, the last available antibiotic class that is sufficiently effective, economical, and feasibly delivered in the outpatient setting are also threatened by evolving resistance. Screening for asymptomatic gonorrhea in women and men who have sex with men, treating with a dual antibiotic regimen, … Show more

Help me understand this page

Search citation statements

Order By: Relevance

Paper Sections

0
0
0
0
0

Citation Types

0
5
0
2

Publication Types

Select...

Relationship

0
0

Authors

Journals